Dhir et al. reported that the likelihood of malignant disease is greater among younger patients, having a larger-sized tumor or being diagnosed with paraganglioma, as well as in patients with mutations in succinate dehydrogenase complex (SDHD) gene (22). This evidence concerns the gene SDHD and neoplasm.